The overexpression of CFI is associated with tumor progression and poor prognosis in several cancers [43,44,45,46], including non-small cell lung cancer [47], likely via immune evasion [45] and tumor cell proliferation, migration, and invasion [44]. The gene discussed is CFI; the disease is non-small cell lung carcinoma.